Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.

Rounis, Konstantinos; Makrakis, Dimitrios; Papadaki, Chara; Monastirioti, Alexia; Vamvakas, Lambros; Kalbakis, Konstantinos; Gourlia, Krystallia; Xanthopoulos, Iordanis et al. · PLoS One · 2023

prospective_cohort · Level II

Where this comes from

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0252537.].